Fifth Third Bancorp’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.02M Sell
51,401
-1,148
-2% -$48.1K ﹤0.01% 1055
2026
Q1
$1.69M Buy
52,549
+52,043
+10,285% +$1.93M ﹤0.01% 1305
2025
Q4
$21.3K Buy
506
+48
+10% +$1.94K ﹤0.01% 1866
2025
Q3
$15.7K Buy
458
+430
+1,536% +$12.3K ﹤0.01% 1986
2025
Q2
$757 Buy
+28
New +$811 ﹤0.01% 2459
2021
Q3
Sell
-5,508
Closed -$220K 2760
2021
Q2
$220K Buy
5,508
+214
+4% +$9.15K ﹤0.01% 950
2021
Q1
$285K Buy
+5,294
New +$305K ﹤0.01% 839
2020
Q2
Sell
-18
Closed 2255
2020
Q1
$0 Buy
+18
New +$453 ﹤0.01% 2309
2019
Q3
Sell
-79
Closed -$2K 2359
2019
Q2
$2K Buy
+79
New +$1.97K ﹤0.01% 2163

Other funds holding VCYT

Fifth Third Bancorp's VCYT Position: Q2 2026 in Review

Fifth Third Bancorp reduced its Veracyte (VCYT) stake by 2.2% in Q2 2026, selling an estimated $48.1K and leaving 51,401 shares worth $3.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1055.

Fifth Third Bancorp first reported a position in VCYT in Q2 2019 and has held it in 9 quarters since. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Fifth Third Bancorp held 51,401 shares of Veracyte worth $3.02M as of Q2 2026.
  • Fifth Third Bancorp sold 1,148 Veracyte shares in Q2 2026, an estimated $48.1K.
  • Veracyte made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #1055 holding.
  • Fifth Third Bancorp first reported a position in Veracyte in Q2 2019 and has held it in 9 quarters since.
  • 371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.